Featured Issue Briefs
The Battle on the Home Front: Jonathan Gadsden's Story
Marine Lance Corporal's story reflects the growing need for new antibiotics that can treat dangerous diseases, against which most drugs are useless. Read More
Facilitating Medical Device Innovation: De Novo Reform
The de novo process -- which requests lower-risk reclassification of medical devices and entry into the marketplace -- as it exists now is not achieving its purpose and has instead added unnecessary and time-consuming requirements. Read More
Food Products Recalled by FDA
Since President Obama signed the FDA Food Safety Modernization Act into law, at least 149 FDA-regulated food products have been recalled due to potential pathogenic contamination. Read More
More Issue Briefs
| Date | Issue Briefs | Topic |
|---|---|---|
| Aug 9, 2012 |
Human Health and Industrial Farming 101Are you interested in writing about the overuse of drugs in food animal production? Below you can find background information, key facts, photos, and other resources. More info |
Antibiotics in Food Animal Production |
| Aug 13, 2012 |
U.S. Senators' Letter to FDA Commissioner Margaret HamburgThirteen U.S. Senators, including Sen. Dianne Feinstein and Sen. Susan Collins signed a letter to U.S. Food and Drug Administration Commissioner Margaret Hamburg calling for improvements to Guidance for Industry 209 -- which proposes voluntary reductions in the use of antibiotics in food animal production. More info |
Antibiotics in Food Animal Production |
| Aug 16, 2012 |
The Battle on the Home Front: The Jonathan Gadsden StorySince Operations Iraqi Freedom and Enduring Freedom began, many American servicemen and women have been infected with antibiotic-resistant bacteria. While our men and women in uniform increasingly survive severe wounds sustained in combat, their injuries leave them susceptible to life-threatening, hard-to-treat infections. Marine Lance Corporal Jonathan Gadsden’s story reflects the growing need for new antibiotics that can treat these dangerous diseases, against which most drugs are useless. More info |
Antibiotic Innovation |
| Aug 23, 2012 |
Pew Biomedical Scholar Profile: Sohini RamachandranSohini Ramachandran, a population geneticist at Brown University in Providence, Rhode Island, received two high-profile awards this year. In June, she was named a Pew Scholar in Biomedical Sciences by the Pew Charitable Trusts, based in Philadelphia, Pennsylvania; and in February, she received a fellowship from the Alfred P. Sloan Foundation in New York. She plans to use the grants to distinguish herself in a fast-moving field. More info |
Biomedical Research |
| Aug 28, 2012 |
Members of Congress Write Letter to FDA About Antibiotics in Food Animal ProductionTwelve United States congressmen have penned a letter to the Food and Drug Administration making recommendations on improvements to the FDA's policies on food animal production and the use of antibiotics in industrial farming. More info |
Antibiotics in Food Animal Production |
| Aug 31, 2012 |
Save Antibiotics August Newsletter (2012)What's in your Lunchbox? & Senators Call for FDA ActionAIP Generating ActBelow is your August 2012 newsletter from the Pew Campaign on Human Health and Industrial Farming. This edition features a video of Supermoms visiting Capitol Hill, a new report on More info |
Antibiotics in Food Animal Production |
| Sep 12, 2012 |
Written Statement of Record Regarding the Sunshine Act by Dr. Daniel J. Carlat of the Pew Health GroupDr. Daniel Carlat, Director of the Pew Prescription Project, appeared before the U.S. Senate Special Committee on Aging to testify about the importance of implementing the Physician Payments Sunshine Act as quickly as possible. More info |
Drug Manufacturing and Distribution, Conflicts of Interest |
| Oct 22, 2012 |
Pew's Comment Letter on FDA’s Advanced Notice of Proposed Rulemaking Regarding Data CollectionOn behalf of The Pew Charitable Trusts (Pew), we are writing to urge the U.S. Food and Drug Administration (FDA) to strengthen regulations pertaining to record-keeping and public reporting of antibiotic use in food animal production. More info |
|
| Nov 8, 2012 |
Pew Comments to the FDA Regarding the Unique Device Identification SystemPew’s Medical Device Initiative, along with the American Heart Association and Trust for America’s Health, submitted comments to the U.S. Food and Drug Administration (FDA) regarding its proposed rule for a unique device identification (UDI) system for medical devices. Once implemented by the FDA and utilized by healthcare providers, the UDI system will be the cornerstone for significant improvements in postmarketing surveillance of medical devices. More info |
Drugs and Devices at the FDA |
| Nov 19, 2012 |
Public Health and Consumer Groups Call for Participation in Antibiotic Use MeetingsOn Nov. 2, 15 public health and consumer organizations sent a joint letter to the FDA requesting to join in discussions to consider how the misuse and overuse of antibiotics in livestock and poultry are significant contributing factors to antibiotic resistance in humans. More info |
Antibiotics in Food Animal Production |
